ReviewCancer journal (Sudbury, Mass.)

Histone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinoma.

Swathi Ramakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.